Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Enliven Therapeutics to Host Webcast Conference Call to Discuss Phase 1 ELVN-001 Clinical Data Being Presented at EHA 2026 Congress
(NASDAQ: ELVN) Delayed: 45.96 +0.86 (1.91%)
Previous Close $45.10    52 Week High $ 
Open $45.26    52 Week Low $ 
Day High $48.52    P/E N/A 
Day Low $45.25    EPS $ 
Volume 2,517,152